LG Chem & TransThera Bio to work on chronic inflammatory conditions

South Korean firm LG Chem Life Sciences, a division of LG Chem, and TransThera Biosciences Co. Ltd., a clinical-stage bi...

August 18, 2020 | Tuesday | News
Novavax, SK Bioscience announce COVID-19 vaccine collaboration

US based Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious di...

August 17, 2020 | Monday | News
Samsung Biologics invests $2B for further expansion

  South Korea based Samsung Biologics held an online press conference to announce its plans to break ground for a ...

August 13, 2020 | Thursday | News
Celltrion to launch antigen and antibody testing kits in US

South Korea based Celltrion Group recently announced the launch of two rapid kits for SARS-CoV-2 in the US by the third ...

August 14, 2020 | Friday | News
Mankind, Daewoong Pharma to use Niclosamide for COVID-19 treatment

Daewoong Pharmaceutical Co. Ltd., South Korea (through its subsidiary, Daewoong Pharmaceutical India Pvt. Ltd.) and Mank...

August 11, 2020 | Tuesday | News
Merck & Hanmi to develop, commercialise therapy for NASH

Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) have announced that the companies have entered in...

August 12, 2020 | Wednesday | News
Samsung Biologics launches S-CHOice cell line expression technology

South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...

August 6, 2020 | Thursday | News
Macrogen obtains CE-IVD mark for COVID-19 test kit

Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...

August 4, 2020 | Tuesday | News
PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC

South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...

August 5, 2020 | Wednesday | News
GC Pharma Files IND for Hyperimmune Globulin-based Therapy for COVID-19

Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...

August 3, 2020 | Monday | News
Seegene receives expanded EUA for COVID-19 diagnostic assay

South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...

July 31, 2020 | Friday | News
Samsung Biologics expands drug product manufacturing facility in Incheon

South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...

July 24, 2020 | Friday | News
Celltrion launches human trial of potential COVID-19 Ab treatment

South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...

July 23, 2020 | Thursday | News
Samsung Biologics announces strong results for Q2 FY21

South Korea based Samsung Biologics recently announced strong financial results for its fiscal 2020 second quarter endin...

July 22, 2020 | Wednesday | News
CGBIO to seize Korean premium filler market

CGBIO, first medical healthcare company to successfully develop an aesthetic premium filler 'Giselleligne' using the R2 ...

July 22, 2020 | Wednesday | News
Korea's VUNO showcases AI-powered radiology solutions at ECR 2020

VUNO Inc., South Korean artificial intelligence (AI) developer is showcasing its solutions at the European Con...

July 15, 2020 | Wednesday | News
BaseLaunch expands pharma-biotech venture funding to APAC

Bridge Biotherapeutics Inc., a clinical-stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunc...

July 17, 2020 | Friday | News
Samsung Biologics, ImmuneOncia enter manufacturing development agreement

South Korea based companies Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to dev...

July 16, 2020 | Thursday | News
AVATAMED Partners CBmed in Europe on Precision Cancer Project

AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, le...

July 13, 2020 | Monday | News
Samsung Biologics signs additional agreement with STCube

South Korea based Samsung Biologics has further expanded its partnership with STCube through an additional development a...

July 14, 2020 | Tuesday | News
WellsCare targets smart health device market

South Korean startup WellsCare, a member company of the Born2Global Centre (B2G), will be expanding its presence in the&...

July 9, 2020 | Thursday | News
Daewoong Pharma expands influence across Asia

Korea's Daewoong Pharmaceutical’s original botulinum toxin product Nabota is stepping up to expand its influence a...

July 8, 2020 | Wednesday | News
Oculight plans expansion in the US market

Oculight announced the launching of OCU L&C, a fully-owned U.S. subsidiary of Oculight, in 2019 as the platform for ...

July 7, 2020 | Tuesday | News
Korea invites global innovators to improve patient care post COVID-19

Janssen Korea Ltd. and Johnson & Johnson Innovation LLC have announced the launch of the Seoul Innovation QuickFire ...

July 6, 2020 | Monday | News
PharmAbcine focuses on Ab therapeutics pipeline in oncology

South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced that it...

July 3, 2020 | Friday | News